Life ScienceCompany
R&D Pharma - Jamaican Interests Ownership
Who owns R&D Pharma - Jamaican Interests?
R&D Pharma - Jamaican Interests is owned by Potent Ventures. It was acquired on February 13, 2019.
R&D Pharma - Jamaican Interests Business Overview
Where is R&D Pharma - Jamaican Interests headquartered?
R&D Pharma - Jamaican Interests is headquartered in Jamaica.
What sector is R&D Pharma - Jamaican Interests in?
R&D Pharma - Jamaican Interests is a life science company.
Life Science M&A Summary in 2019
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.
Join Mergr to view all 252 acquisitions of life science companies in 2019, including 45 acquisitions by private equity firms, and 207 by strategics.